(Q87124436)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26791893%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

title

Recent advances in the construction of antibody-drug conjugates (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26791893%20AND%20SRC:MED&resulttype=core&format=json

Corrigendum: Recent advances in the construction of antibody-drug conjugates

5 March 2020

corrigendum / erratum

0 references

author

Vijay Chudasama

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26791893%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Stephen Caddick

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26791893%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

author name string

Antoine Maruani

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26791893%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

publication date

4 January 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26791893%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26791893%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26791893%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26791893%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

page(s)

114-119

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26791893%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/nchem.2415

5 March 2020

exact match

0 references

cites work

Maturing antibody-drug conjugate pipeline hits 30.

1 reference

12 December 2020

Preparation and characterization of monoclonal antibody conjugates of the calicheamicins: a novel and potent family of antitumor antibiotics

1 reference

12 December 2020

Development of potent monoclonal antibody auristatin conjugates for cancer therapy

1 reference

12 December 2020

Trastuzumab emtansine for HER2-positive advanced breast cancer

1 reference

12 December 2020

Preparation of well-defined antibody-drug conjugates through glycan remodeling and strain-promoted azide-alkyne cycloadditions

1 reference

12 December 2020

Functional native disulfide bridging enables delivery of a potent, stable and targeted antibody-drug conjugate (ADC)

1 reference

12 December 2020

A plug-and-play approach to antibody-based therapeutics via a chemoselective dual click strategy.

1 reference

12 December 2020

Cure of xenografted human carcinomas by BR96-doxorubicin immunoconjugates

1 reference

12 December 2020

Site-selective multi-porphyrin attachment enables the formation of a next-generation antibody-based photodynamic therapeutic.

1 reference

12 December 2020

Long-term tumor regression induced by an antibody-drug conjugate that targets 5T4, an oncofetal antigen expressed on tumor-initiating cells

1 reference

12 December 2020

An anti-MUC1 antibody-calicheamicin conjugate for treatment of solid tumors. Choice of linker and overcoming drug resistance

1 reference

12 December 2020

[Effect on mouse leukemia 1210 of a combination by diazo-reaction of amethopterin and gamma-globulins from hamsters inoculated with such leukemia by heterografts.]

1 reference

12 December 2020

Bridging disulfides for stable and defined antibody drug conjugates

1 reference

12 December 2020

Antibody as carrier of chlorambucil

1 reference

12 December 2020

Suppression of tumour growth in mice by a drug–antibody conjugate using a novel approach to linkage

1 reference

12 December 2020

Localisation and toxicity study of a vindesine-anti-CEA conjugate in patients with advanced cancer

1 reference

12 December 2020

Site-specific and stoichiometric modification of antibodies by bacterial transglutaminase

1 reference

12 December 2020

Location matters: site of conjugation modulates stability and pharmacokinetics of antibody drug conjugates

1 reference

12 December 2020

Reduction-alkylation strategies for the modification of specific monoclonal antibody disulfides

1 reference

12 December 2020

Self-hydrolyzing maleimides improve the stability and pharmacological properties of antibody-drug conjugates

1 reference

12 December 2020

Glycosylation of recombinant antibody therapeutics

1 reference

12 December 2020

Site-specific antibody-drug conjugation through glycoengineering.

1 reference

12 December 2020

Effects of drug loading on the antitumor activity of a monoclonal antibody drug conjugate

1 reference

12 December 2020

Site-specific chemical modification of recombinant proteins produced in mammalian cells by using the genetically encoded aldehyde tag

1 reference

12 December 2020

Synthesis of site-specific antibody-drug conjugates using unnatural amino acids

1 reference

12 December 2020

Aldehyde tag coupled with HIPS chemistry enables the production of ADCs conjugated site-specifically to different antibody regions with distinct in vivo efficacy and PK outcomes

1 reference

12 December 2020

Address in Pathology, ON CHEMIOTHERAPY: Delivered before the Seventeenth International Congress of Medicine

1 reference

12 December 2020

Site specific protein labeling by enzymatic posttranslational modification.

1 reference

12 December 2020

Production of site-specific antibody-drug conjugates using optimized non-natural amino acids in a cell-free expression system

1 reference

12 December 2020

A general approach to site-specific antibody drug conjugates

1 reference

12 December 2020

The discovery and development of brentuximab vedotin for use in relapsed Hodgkin lymphoma and systemic anaplastic large cell lymphoma

1 reference

12 December 2020

Primary structure of microbial transglutaminase from Streptoverticillium sp. strain s-8112

1 reference

12 December 2020

Rapid identification of reactive cysteine residues for site-specific labeling of antibody-Fabs

1 reference

12 December 2020

Site-specific chemical protein conjugation using genetically encoded aldehyde tags

1 reference

12 December 2020

An enhanced system for unnatural amino acid mutagenesis in E. coli

1 reference

12 December 2020

Antibody-targeted drugs for the therapy of cancer

1 reference

12 December 2020

Brentuximab vedotin (SGN-35) for relapsed CD30-positive lymphomas

1 reference

12 December 2020

Trastuzumab emtansine: a unique antibody-drug conjugate in development for human epidermal growth factor receptor 2-positive cancer

1 reference

12 December 2020

Investigation into temperature-induced aggregation of an antibody drug conjugate

1 reference

12 December 2020

Impact of methionine oxidation in human IgG1 Fc on serum half-life of monoclonal antibodies

1 reference

12 December 2020

Antineoplastic efficacy of doxorubicin enzymatically assembled on galactose residues of a monoclonal antibody specific for the carcinoembryonic antigen

1 reference

12 December 2020

Multidrug-resistance phenotype and clinical responses to gemtuzumab ozogamicin

1 reference

12 December 2020

Site-specific attachment to recombinant antibodies via introduced surface cysteine residues

1 reference

12 December 2020

Carbohydrate-binding protein 35 (Mac-2), a laminin-binding lectin, forms functional dimers using cysteine 186.

1 reference

12 December 2020

Transglutaminases: multifunctional cross‐linking enzymes that stabilize tissues

1 reference

12 December 2020

Crystal structure of microbial transglutaminase from Streptoverticillium mobaraense

1 reference

12 December 2020

Homo-oligomerization of the porcine reproductive and respiratory syndrome virus nucleocapsid protein and the role of disulfide linkages

1 reference

12 December 2020

Site-specific conjugation of a cytotoxic drug to an antibody improves the therapeutic index.

1 reference

12 December 2020

Conjugation site modulates the in vivo stability and therapeutic activity of antibody-drug conjugates.

1 reference

12 December 2020

Next-generation disulfide stapling: reduction and functional re-bridging all in one.

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FNCHEM.2415

7 January 2021